Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab
Josette Carnahan(Amgen (United States)), Rhona Stein(Center for Molecular Medicine and Immunology), Zhengxing Qu(Immunomedics (United States)), Kristen L. Hess(Amgen (United States)), Alessandra Cesano(Amgen (United States)), Hans J. Hansen(Immunomedics (United States)), David M. Goldenberg(Immunomedics (United States))
Cited by 173
Abstract
Related Papers
No related papers found
Powered by citation graph analysis